LONDON (AP) — Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer. Recommended Stories Sole Democratic FCC commissioner warns Disney it’s a ‘target’ of censorship campaign Crowdfunding campaign to buy Spirit Airlines takes off to the tune of $337 million ABC takes FCC to task over equal airtime dispute involving The View